550
panel
Open Private Breakfast (Invite only)
panel
Open Private Session (Invite only)
panel
Open Private Session (Invite only)
podcast episode
Ep. 89: Impact, with GPIF’s Hiro Mizuno
“For us to have a sustainable portfolio, we have to have a sustainable capital market. And for us
to have a sustainable capital market, we need to have a sustainable society.
+ Read More
podcast episode
Ep. 90: Well-Being, with the Motsepe Foundation’s Precious Moloi-Motsepe
“Your well-being, your wealth, is very intertwined and dependent on other people's well-being....T
hat is the philosophy that also drives us because we know that our children's well-being cannot be isolated from the well-being of the other childr
+ Read More
podcast episode
Ep. 95:Real Impact, with Jennifer Doudna
“I really want to be building on this technology here at Berkeley and making sure that we are crea
ting a community of scientists that are doing two things: not only extending this extraordinary science and thinking about how to apply genome editing in w
+ Read More
podcast episode
Ep. 116: Encore, with Sherry Lansing
“When we get out of this pandemic, I suspect people are going to want to flock to the movie theate
rs. But they're also going to say, I still want my content delivered. So, the movie industry is going to face a decision.
+ Read More
podcast episode
Ep. 115: New Heroes, with NIH's Francis Collins
“It has been a year of terrible tragedy. … And yet, it's also been a year of heroism: the first re
sponders, the healthcare providers, putting themselves at risk to try to help those who are suffering.
+ Read More
podcast episode
Ep. 111: Global Scale, with Leaders from Murdoch Children’s Research Institute
“With COVID, there's been this renewed focus on the importance of medical research...With more fun
ding and with philanthropic partners, I'm really optimistic about the further impact that we can make on that global scale.” - Sarah Murdoch, of th
+ Read More
podcast episode
Ep. 113: "To Boldly Go," with Operation Warp Speed's Moncef Slaoui
“The efficacy of these vaccines is spectacular. It's 95%, the same whether you are an African-Amer
ican or Hispanic or over 65 years old.
+ Read More
podcast episode
Ep. 112: Speed of Science, with Pfizer’s Albert Bourla and Johnson & Johnson’s Alex Gorsky
“I think history has shown us to have major leaps forward almost after every crisis.